Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity. | Radiol Oncol | 2022 | 35390246 | PubTator, text mining | PubMed |
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families? | Int J Oncol | 2022 | 35383859 | PubTator, text mining | PubMed |
| BAP1-defficient breast cancer in a patient with BAP1 cancer syndrome. | Breast Cancer | 2022 | 35381901 | PubTator, text mining | PubMed |
| Antibodies as biomarkers for cancer risk: a systematic review. | Clin Exp Immunol | 2022 | 35380164 | PubTator, text mining | PubMed |
| Breast cancer screening and early diagnosis in Chinese women. | Cancer Biol Med | 2022 | 35380032 | PubTator, text mining | PubMed |
| A Novel Prognostic Model for Identifying the Risk of Hepatocellular Carcinoma Based on Angiogenesis Factors. | Front Genet | 2022 | 35368665 | PubTator, text mining | PubMed |
| SEOM-GETTHI clinical guideline for the practical management of molecular platforms (2021). | Clin Transl Oncol | 2022 | 35362851 | PubTator, text mining | PubMed |
| Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies. | Curr Oncol Rep | 2022 | 35362827 | PubTator, text mining | PubMed |
| Cell cycle regulation: p53-p21-RB signaling. | Cell Death Differ | 2022 | 35361964 | PubTator, text mining | PubMed |
| Germline Mutation Analysis in Sporadic Breast Cancer Cases With Clinical Correlations. | Front Genet | 2022 | 35356428 | PubTator, text mining | PubMed |
| Bcl-3: A Double-Edged Sword in Immune Cells and Inflammation. | Front Immunol | 2022 | 35355979 | PubTator, text mining | PubMed |
| Mutational spectrum of breast cancer susceptibility genes among women ascertained in a cancer risk clinic in Northeast Brazil. | Breast Cancer Res Treat | 2022 | 35353237 | PubTator, text mining | PubMed |
| BRCA1/BARD1 is a nucleosome reader and writer. | Trends Biochem Sci | 2022 | 35351360 | PubTator, text mining | PubMed |
| N-glycolylneuraminic acid serum biomarker levels are elevated in breast cancer patients at all stages of disease. | BMC Cancer | 2022 | 35346112 | PubTator, text mining | PubMed |
| Myeloproliferative neoplasm with basophilia and abnormality of platelet-derived growth factor receptor a translocation: a case report. | Blood Res | 2022 | 35342043 | PubTator, text mining | PubMed |
| Preoperative Radiomics Analysis of Contrast-Enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2022 | 35340666 | PubTator, text mining | PubMed |
| Uncovering post-translational modification-associated protein-protein interactions. | Curr Opin Struct Biol | 2022 | 35334254 | PubTator, text mining | PubMed |
| Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma. | BMC Cancer | 2022 | 35331190 | PubTator, text mining | PubMed |
| PARP Inhibitors as Monotherapy in Daily Practice for Advanced Prostate Cancers. | J Clin Med | 2022 | 35330059 | PubTator, text mining | PubMed |
| Insights in Post-Translational Modifications: Ubiquitin and SUMO. | Int J Mol Sci | 2022 | 35328702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=59